National Seasonal Influenza Vaccination Survey in Europe, 2008

Mereckiene, Jolita; Cotter, Suzanne; Nicoll, A; Lévy-Brühl, Daniel; Ferro, António; Tridente, Giuseppe; Zanoni, Giovanna; Berra, P; Salmaso, Stefania; O’Flanagan, D

doi:10.2807/ese.13.43.19017-en

Cited by 104 publications

(81 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…31 Finally, data from Greece suggests that this country has lower coverage rates among all high risk (, 20% for chronic lung disease) groups than other European countries. 32 Several studies have been performed in Spain using primary care databases 9,26 17,24,[29][30][31][32][33][34][35][36] We believe that the possible reasons for such high coverage among the older Spanish population may be as a consequence of; (1) a well-organized public health service that provides vaccination free of charge to this age group; (2) the effect of annual mass media campaigns (TV, radio and newspapers); (3) good promotion of vaccination campaigns by health care workers. 7,[22][23][24][25][26] Several published articles specifically analyze the factors associated with a greater probability of influenza vaccination among individuals who have chronic lung disease.…”

Section: Discussionmentioning

confidence: 99%

“…This data are important as it informs quality decision making around the establishment of vaccination programs in different countries. 17 In Spain, previous studies using representative samples of patients with chronic pulmonary diseases have shown vaccination coverage to be between 41% and 87%. [22][23][24][25] Using data obtained from the European Health Survey for Spain (EHS) the objectives of our study are:…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Influenza vaccination coverage and uptake predictors among Spanish adults suffering COPD

Santos-Sancho

Jiménez‐Trujillo

Hernández-Barrera

et al. 2012

Human Vaccines & Immunotherapeutics

View full text Add to dashboard Cite

Abbreviations: chronic obstructive pulmonary disease, COPDThe aim of this study is to compare influenza vaccination coverage among Spaniards aged 40 y or over who suffer from chronic obstructive pulmonary disease (COPD) with those without this illness to identify the factors that influence vaccination uptake among patients with COPD.Data was extracted from the European Health Survey performed in Spain in 2009/10, and analyzed data on 15,355 Spaniards ($ 40 y of age), of whom 1,309 (8.2% 95% CI 7.7-8.7) had COPD was used. We considered the answer (yes/no) to the question about whether or not the interviewed person had been vaccinated against influenza in the previous flu season. We used the answer to this question as the dependent variable. For independent variables, we analyzed social demographic characteristics, health related variables, and the utilization of health care services.Vaccination coverage among patients with COPD is 49.4% (95% CI: 46.3-52.5%) and 21.3% (95% CI: 20.7-21.9) among people without (p , 0.001). The probability of being vaccinated is three times greater for COPD patients (crude OR = 3.0, 95% CI: 2.6-3.5). Among COPD patients the uptake of vaccination increased with age. Other factors associated with an increase in vaccination coverage were: being male, perceiving one's health as fair or poor, not smoking and having seen a doctor during the previous month.The rate of flu vaccination among adult Spaniards with COPD is lower than desired. Urgent strategies for increasing vaccination coverage are necessary for COPD sufferers aged under 65 of age and those with unhealthy lifestyles.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Influenza vaccination coverage and uptake predictors among Spanish adults suffering COPD

Santos-Sancho

Jiménez‐Trujillo

Hernández-Barrera

et al. 2012

Human Vaccines & Immunotherapeutics

View full text Add to dashboard Cite

show abstract

“…The European Centre for Disease Prevention and Control (ECDC) is to provide technical support from its Seasonal Influenza Immunisation Programme including its work with the Vaccine European New Integrated Collaboration Effort (VENICE) project to monitor policies, practices and coverage. Much is to be done, as uptake in the older age groups varies forty-fold between Member States, some countries cannot provide data at all, and most find it difficult to monitor coverage in the clinical risk groups [19]. A group especially singled out for attention and immunisation by the European Council are healthcare workers (HCW).…”

Section: So What Happens Next and What Needs To Be Done?mentioning

confidence: 99%

A new decade, a new seasonal influenza: the Council of the European Union Recommendation on seasonal influenza vaccination

Nicoll

2010

Eurosurveillance

Self Cite

View full text Add to dashboard Cite

“…Thus, annual vaccination against influenza is recommended for health-care workers and students in the health professions 8,21 . However, the vaccination coverage in both groups has been universally low, Brazil included 5,11,16,20,25,29,33,35 . Among health-care workers, misconceptions about the seasonal influenza vaccine and the disease have been identified in review studies as significant barriers to the acceptance of the vaccine 13,14 .…”

Section: Introductionmentioning

confidence: 99%

Pandemic influenza A/H1N1 vaccination coverage, adverse reactions, and reasons for vaccine refusal among medical students in Brazil

Souza

Teixeira

2012

Rev. Inst. Med. trop. S. Paulo

View full text Add to dashboard Cite

The aim of this cross-sectional study was to determine, among medical students at a public university in Rio de Janeiro, Brazil, the acceptance of the pandemic influenza A/H1N1 vaccine during the 2010 mass immunization campaign and the vaccine safety in this group and, among unvaccinated students, the reasons for refusing vaccination. Of a total of 858 students, 678 (79%) participated in the study. Vaccination coverage was 60.4% among students aged 20 to 39 years (an age group targeted for vaccination) and 43.8% among those who did not belong to this age group. The most frequent adverse reactions to the vaccine were pain at the injection site (8.7%) and fever (7.9%). There were no serious adverse reactions. Among students aged 20 to 39 years, the most common reasons for refusing the vaccine were "lack of time" (42.4%), "fear of adverse reactions" (41.9%), and "difficult access to the vaccine" (11.5%). Other reasons for vaccine refusal were "uncertainties about vaccine safety and efficacy" and "vaccination was not needed". To increase the acceptance of the influenza vaccine, a comprehensive immunization program should be offered to these students.

show abstract

National Seasonal Influenza Vaccination Survey in Europe, 2008

Abstract: Binary file ES_Abstracts_Final_ECDC.txt matches

Cited by 104 publications

References 7 publications

Influenza vaccination coverage and uptake predictors among Spanish adults suffering COPD

Influenza vaccination coverage and uptake predictors among Spanish adults suffering COPD

A new decade, a new seasonal influenza: the Council of the European Union Recommendation on seasonal influenza vaccination

Pandemic influenza A/H1N1 vaccination coverage, adverse reactions, and reasons for vaccine refusal among medical students in Brazil

Contact Info

Product

Resources

About